TABLE OF CONTENTS
Volume 33, Issue 8 (April (2) 2004)
Cytoreduction Regimens |
Sickle Cell Disease |
Paediatric Leukemia |
Myeloma |
Amegakaryocytic Thrombocytopenia |
Graft-Versus-Host Disease |
Immune Reconstitution |
Pharmacokinetics |
Donor Assessment |
Case Reports |
Correspondence
Mini Review
Will regulation be the death of cell therapy in the United States? FREE
D A Gastineau
Bone Marrow Transplant 33: 777-780; advance online publication, February 16, 2004; doi:10.1038/sj.bmt.1704452
Cytoreduction Regimens
Activity of single-agent melphalan 220–300 mg/m2 with amifostine cytoprotection and autologous hematopoietic stem cell support in non-Hodgkin and Hodgkin lymphoma FREE
G L Phillips, B R Meisenberg, D E Reece, V R Adams, A Z Badros, J L Brunner, R G Fenton, J Filicko, D L Grosso, G A Hale, D S Howard, V P Johnson, A Kniska, K W Marshall, B Mookerjee, R Nath, A P Rapoport, C Sarkodee-Adoo, N Takebe, D H Vesole, J L Wagner and N Flomenberg
Bone Marrow Transplant 33: 781-787; advance online publication, February 9, 2004; doi:10.1038/sj.bmt.1704424
Thiotepa/cyclophosphamide/TBI as a conditioning regimen for allogeneic hematopoietic stem cell transplantation in patients with myelodysplastic syndrome FREE
K Fujimaki, J Taguchi, H Fujita, M Hattori, E Yamazaki, N Takahashi, S Fujisawa, H Kanamori, A Maruta and Y Ishigatsubo
Bone Marrow Transplant 33: 789-792; advance online publication, March 8, 2004; doi:10.1038/sj.bmt.1704451
Oxidative study of patients with total body irradiation: effects of amifostine treatment FREE
G Facorro, M M Sarrasague, H Torti, A Hager, J S Avalos, M Foncuberta and G Kusminsky
Bone Marrow Transplant 33: 793-798; advance online publication, March 8, 2004; doi:10.1038/sj.bmt.1704427
Sickle Cell Disease
Hydroxyurea treatment for sickle cell disease: impact on haematopoietic stem cell transplantation's outcome FREE
C Brachet, N Azzi, A Demulder, C Devalck, A Gourdin, B Gulbis, A Klein, P Q Le, M Loop, E Sariban and A Ferster
Bone Marrow Transplant 33: 799-803; advance online publication, February 9, 2004; doi:10.1038/sj.bmt.1704443
Paediatric Leukemia
Allogeneic bone marrow transplantation in children with myelodysplastic syndrome or juvenile myelomonocytic leukemia: the Seattle experience FREE
U Yusuf, H A Frangoul, T A Gooley, A E Woolfrey, P A Carpenter, R G Andrews, H J Deeg, F R Appelbaum, C Anasetti, R Storb and J E Sanders
Bone Marrow Transplant 33: 805-814; advance online publication, February 2, 2004; doi:10.1038/sj.bmt.1704438
Increasing mixed chimerism defines a high-risk group of childhood acute myelogenous leukemia patients after allogeneic stem cell transplantation where pre-emptive immunotherapy may be effective FREE
P Bader, H Kreyenberg, W Hoelle, G Dueckers, B Kremens, D Dilloo, K-W Sykora, C Niemeyer, D Reinhardt, J Vormoor, B Gruhn, P Lang, J Greil, R Handgretinger, D Niethammer, T Klingebiel and J F Beck
Bone Marrow Transplant 33: 815-821; advance online publication, March 1, 2004; doi:10.1038/sj.bmt.1704444
Myeloma
Dialysis-dependent renal failure in patients with myeloma can be reversed by high-dose myeloablative therapy and autotransplant FREE
C-K Lee, M Zangari, B Barlogie, A Fassas, F van Rhee, R Thertulien, G Talamo, F Muwalla, E Anaissie, K Hollmig and G Tricot
Bone Marrow Transplant 33: 823-828; advance online publication, February 9, 2004; doi:10.1038/sj.bmt.1704440
Amegakaryocytic Thrombocytopenia
Allogeneic stem cell transplantation for patients with congenital amegakaryocytic thrombocytopenia (CAT) FREE
A Al-Ahmari, M Ayas, A Al-Jefri, M Al-Mahr, S Rifai and H El Solh
Bone Marrow Transplant 33: 829-831; advance online publication, February 16, 2004; doi:10.1038/sj.bmt.1704445
Graft-Versus-Host Disease
Low-dose alemtuzumab (Campath®) in myeloablative allogeneic stem cell transplantation for CD52-positive malignancies: decreased incidence of acute graft-versus-host-disease with unique pharmacokinetics FREE
I F Khouri, M Albitar, R M Saliba, C Ippoliti, Y C Ma, M J Keating and R E Champlin
Bone Marrow Transplant 33: 833-837; advance online publication, February 2, 2004; doi:10.1038/sj.bmt.1704435
Immune Reconstitution
Cytomegalovirus-specific immune recovery following allogeneic HLA-identical sibling transplantation with reduced-intensity preparative regimen FREE
M Mohty, A M Mohty, D Blaise, C Faucher, K Bilger, D Isnardon, D Sainty, J A Gastaut, P Viens, D Olive and B Gaugler
Bone Marrow Transplant 33: 839-846; advance online publication, February 9, 2004; doi:10.1038/sj.bmt.1704442
Pharmacokinetics
Pharmacokinetics and effects on bowel and throat microflora of oral levofloxacin as antibacterial prophylaxis in neutropenic patients with haematological malignancies FREE
G J Timmers, Y Dijstelbloem, A M Simoons-Smit, A J van Winkelhoff, D J Touw, C M J E Vandenbroucke-Grauls and P C Huijgens
Bone Marrow Transplant 33: 847-853; advance online publication, February 2, 2004; doi:10.1038/sj.bmt.1704431
Donor Assessment
Bone marrow aspirates as part of routine donor assessment for allogeneic blood and marrow transplantation can reveal presence of occult hematological malignancies in otherwise asymptomatic individuals FREE
T L Kiss, H Chang, A Daly, H A Messner, N Jamal, D Spaner, S Rubin and J H Lipton
Bone Marrow Transplant 33: 855-858; advance online publication, March 1, 2004; doi:10.1038/sj.bmt.1704430
Case Reports
Contemporaneous appearance, 18 years after allogeneic bone marrow transplantation, of myelodysplastic syndrome in the patient and the donor FREE
E Orciuolo, A Azzarà, G Bandini, S Galimberti, F Bonifazi, R Fazzi and M Petrini
Bone Marrow Transplant 33: 859-861; advance online publication, January 26, 2004; doi:10.1038/sj.bmt.1704417
Autologous hematopoietic stem cell transplantation for refractory antiphospholipid syndrome causing myocardial necrosis FREE
N Hashimoto, T Iwasaki, M Sekiguchi, H Takatsuka, T Okamoto, T Hashimoto and H Sano
Bone Marrow Transplant 33: 863-866; advance online publication, February 2, 2004; doi:10.1038/sj.bmt.1704432
Correspondence
Acute pancreatitis due to tacrolimus in a case of allogeneic bone marrow transplantation FREE
J Sastry, S Young and P J Shaw
Bone Marrow Transplant 33: 867-868; advance online publication, January 26, 2004; doi:10.1038/sj.bmt.1704429
Extracorporeal photochemotherapy for treatment of fasciitis in chronic graft-versus-host disease FREE
P Sbano, P Rubegni, G B De Aloe, S Guidi and M Fimiani
Bone Marrow Transplant 33: 869-870; advance online publication, January 26, 2004; doi:10.1038/sj.bmt.1704436
Variations in 1
,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 serum levels during allogeneic bone marrow transplantation FREE
M Kreutz, G Eissner, J Hahn, R Andreesen, W Drobnik and E Holler
Bone Marrow Transplant 33: 871-873; advance online publication, January 26, 2004; doi:10.1038/sj.bmt.1704448
Unrelated cord blood transplantation in an infant with severe multisystem Langerhans cell histiocytosis: clinical outcome, engraftment and culture of monocyte-derived dendritic cells FREE
F Meyer-Wentrup, J Foell, A Wawer and S Burdach
Bone Marrow Transplant 33: 875-876; advance online publication, January 26, 2004; doi:10.1038/sj.bmt.1704441
Partial immune reconstitution after bone marrow transplantation in a boy with recombination activating gene 1 defect FREE
J Muñoz-Robles, M J Del Rey, J Ruiz-Contreras, J Clemente, J T Ramos, E Paz-Artal and L M Allende
Bone Marrow Transplant 33: 877-878; advance online publication, March 1, 2004; doi:10.1038/sj.bmt.1704447
Correction of persistent thrombocytopenia by a boost of CD133+ selected stem cells in a patient transplanted for Wiskott-Aldrich syndrome 10 years ago FREE
P Lang, T Klingebiel, M Schumm, R Handgretinger, J Greil, J F Beck, D Niethammer and P Bader
Bone Marrow Transplant 33: 879-880; advance online publication, January 26, 2004; doi:10.1038/sj.bmt.1704434
